Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125312
Filing Date
2024-11-12
Accepted
2024-11-12 16:02:55
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prok-20240930.htm   iXBRL 10-Q 1897278
2 EX-31.1 prok-ex31_1.htm EX-31.1 16951
3 EX-31.2 prok-ex31_2.htm EX-31.2 16933
4 EX-32.1 prok-ex32_1.htm EX-32.1 9697
5 EX-32.2 prok-ex32_2.htm EX-32.2 9710
  Complete submission text file 0000950170-24-125312.txt   8106066

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20240930.xsd EX-101.SCH 1225368
66 EXTRACTED XBRL INSTANCE DOCUMENT prok-20240930_htm.xml XML 1435540
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40560 | Film No.: 241447844
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)